Literature DB >> 9409426

Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients.

Y Matsushima1, M Aoyagi, T Nariai, Y Takada, K Hirakawa.   

Abstract

Long term post-encephalo-duro-arterio-synangiosis (EDAS) intelligence quotient (IQ) evaluated by Wechsler tests stays around the normal range (mean full intelligence quotient (FIQ), verbal intelligence quotient (VIQ) and performance intelligence quotient (PIQ) at 100.0 +/- 155, 100.0 +/- 15.7 and 100.2 +/- 163, respectively) at more than 9.5 years after the operation, provided that the patient has FIQ above 70 pre-operatively. This fact encourages us to employ operative treatment for this difficult disease in which intelligence deterioration has been reported to be a common occurrence.

Entities:  

Mesh：

Year:  1997        PMID： 9409426     DOI： 10.1016/s0303-8467(97)00055-3

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


  8 in total

1.  Moyamoya disease and surgical intervention.

Authors:  Jay W Rhee; Suresh N Magge
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

2.  Neuropsychological impacts of indirect revascularization for pediatric moyamoya disease.

Authors:  WooHyun Kim; Eun-Young Lee; Seong-Eun Park; Eun-Kyung Park; Ju-Seong Kim; Dong-Seok Kim; Kyu-Won Shim
Journal:  Childs Nerv Syst       Date:  2018-04-20       Impact factor: 1.475

3.  Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis.

Authors:  Satoshi Kuroda; Kiyohiro Houkin; Tatsuya Ishikawa; Naoki Nakayama; Jun Ikeda; Nobuaki Ishii; Hiroyasu Kamiyama; Yoshinobu Iwasaki
Journal:  Childs Nerv Syst       Date:  2004-03-24       Impact factor: 1.475

Review 4.  Cognitive Outcome of Pediatric Moyamoya Disease.

Authors:  Kyu-Won Shim; Eun-Kyung Park; Ju-Seong Kim; Dong-Seok Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 5.  Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.

Authors:  Takeshi Funaki; Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-21       Impact factor: 1.742

6.  ＜Editors' Choice＞ Indocyanine green emission timing of the recipient artery in revascularization surgery for moyamoya disease.

Authors:  Fumiaki Kanamori; Yoshio Araki; Kinya Yokoyama; Kenji Uda; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Sho Okamoto; Atsushi Natsume
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

7.  Characterizing the neurocognitive profiles of children with moyamoya disease using the Das Naglieri cognitive assessment system.

Authors:  Yusuke Kusano; Takeshi Funaki; Keita Ueda; Noyuri Nishida; Kanade Tanaka; Susumu Miyamoto; Shuichi Matsuda
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

8.  Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Annick Kronenburg; Esther van den Berg; Monique M van Schooneveld; Kees P J Braun; Lionel Calviere; Albert van der Zwan; Catharina J M Klijn
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.